Literature DB >> 16145373

Is renal sinus fat invasion the same as perinephric fat invasion for pT3a renal cell carcinoma?

R Houston Thompson1, Bradley C Leibovich, John C Cheville, W Scott Webster, Christine M Lohse, Eugene D Kwon, Igor Frank, Horst Zincke, Michael L Blute.   

Abstract

PURPOSE: Perinephric and renal sinus fat invasion are classified as pT3a renal cell carcinoma (RCC) according to the 2002 American Joint Committee on Cancer. We investigated the prognostic significance of each of these pathological features using a cohort of pT3a patients.
MATERIALS AND METHODS: Between 1970 and 2002, 205 patients without direct adrenal invasion underwent nephrectomy for pT3a clear cell RCC. The associations of fat invasion with death from RCC were evaluated using Cox proportional hazards regression models.
RESULTS: Of the 162 patients with perinephric fat invasion and 43 patients with renal sinus fat invasion 95 (59%) and 31 (72%), respectively, died of RCC. Patients with renal sinus fat invasion were 63% more likely to die of RCC compared with those with perinephric fat invasion (RR 1.63, 95% CI 1.09-2.46, p=0.018). In addition, the risk of death persisted in multivariate analysis after adjusting for regional lymph nodes and distant metastases (RR 1.91, 95% CI 1.26-2.89, p=0.002) and after adjusting for the Mayo Clinic SSIGN (stage, size, grade and necrosis) score (RR 1.90, 95% CI 1.25-2.88, p=0.003).
CONCLUSIONS: Our results indicate that clear cell tumors invading the renal sinus fat are more aggressive than tumors with perinephric fat involvement. We believe both of these features should be individually assessed during routine pathological examination. External validation is needed before suggesting a change to the TNM staging system.

Entities:  

Mesh:

Year:  2005        PMID: 16145373     DOI: 10.1097/01.ju.0000173942.19990.40

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  22 in total

1.  Prognostic impact of muscular venous branch invasion in localized renal cell carcinoma cases.

Authors:  Andrew Feifer; Caroline Savage; Heidi Rayala; William Lowrance; Geoffrey Gotto; Preston Sprenkle; Amit Gupta; Jennifer Taylor; Melanie Bernstein; Adebowale Adeniran; Satish K Tickoo; Victor E Reuter; Paul Russo
Journal:  J Urol       Date:  2010-11-12       Impact factor: 7.450

2.  Pathologic T3a renal cell carcinoma: a classification in need of further refinement.

Authors:  John M DiBianco; Patrick T Gomella; Mark W Ball
Journal:  Ann Transl Med       Date:  2018-12

Review 3.  Prognostic factors in renal cell carcinoma.

Authors:  Alessandro Volpe; Jean Jacques Patard
Journal:  World J Urol       Date:  2010-04-03       Impact factor: 4.226

Review 4.  Percutaneous biopsy for risk stratification of renal masses.

Authors:  Michael L Blute; Anna Drewry; Edwin Jason Abel
Journal:  Ther Adv Urol       Date:  2015-10

5.  Advances of multidetector computed tomography in the characterization and staging of renal cell carcinoma.

Authors:  Athina C Tsili; Maria I Argyropoulou
Journal:  World J Radiol       Date:  2015-06-28

6.  Partial versus radical nephrectomy for 4 to 7 cm renal cortical tumors.

Authors:  R Houston Thompson; Sameer Siddiqui; Christine M Lohse; Bradley C Leibovich; Paul Russo; Michael L Blute
Journal:  J Urol       Date:  2009-10-17       Impact factor: 7.450

Review 7.  The changing face of renal cell carcinoma pathology.

Authors:  Hakan Aydin; Ming Zhou
Journal:  Curr Oncol Rep       Date:  2008-05       Impact factor: 5.075

8.  Approach to the small renal mass: weighing treatment options.

Authors:  Brian M Benway; Sam B Bhayani
Journal:  Curr Urol Rep       Date:  2009-01       Impact factor: 3.092

9.  The importance of histology and cytogenetics in decision making for renal cell carcinoma.

Authors:  Julia G Garcia; Maria M Picken; Robert C Flanigan
Journal:  World J Urol       Date:  2008-04-08       Impact factor: 4.226

10.  Staging of renal cell carcinoma: Current concepts.

Authors:  John S Lam; Tobias Klatte; Alberto Breda
Journal:  Indian J Urol       Date:  2009 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.